Profile
International Journal of Clinical & Medical Microbiology Volume 2 (2017), Article ID 2:IJCMM-123, 4 pages
https://doi.org/10.15344/2456-4028/2017/123
Research Article
Enterococcus faecium L-3 in Eradication of Helicobacter pylori: In-vivo and In-vitro

Natalia Baryshnikova1*, Elene Ermolenko2, 3, Alena Svarval4, Raya Ferman4, Alexander Colobov5 , Galina Alechina2 , Natalia Roshina4 , Yury Uspenskiy1, Thomas Haertlé 6 and Alexander Suvorov2,3

1Pavlov First St-Petersburg State Medical University, ul. Lva Tolstogo, 6-8, Sankt-Peterburg, 197022, Russia
2Institute of Experimental Medicine, St-Petersburg, Russia
3St-Petersburg State University, University Embankment, 7/9, Sankt-Peterburg, 199034, Russia
4Pasteur Institute, St-Petersburg, Russia
5Institute of Pure Biochemicals, St-Petersburg, Russia
6INRA, Nantes, France
Dr. Natalia Baryshnikova, Pavlov First St-Petersburg State Medical University, ul. Lva Tolstogo, 6-8, Sankt-Peterburg, 197022, Russia; E-mail: baryshnikova_nv@mail.ru
05 June 2017; 07 October 2017; 09 October 2017
Baryshnikova N, Ermolenko E, Svarval A, Ferman R, Colobov A , et al. (2017) Enterococcus faecium L-3 in Eradication of Helicobacter pylori: In-vivo and In-vitro. Int J Clin Med Microbiol 2: 123. doi: https://doi.org/10.15344/2456-4028/2017/123
The study was supported by Russian scientific foundation grant 16- 15-10085 and international grant with INRA France 14.616.21.0024.

References

  1. Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, et al. (2017) Management of Helicobacter pylori infection-the Maastricht V/ Florence Consensus Report. Gut 66: 6-30 [CrossRef] [Google Scholar] [PubMed]
  2. Coconnier MH, Liévin V, Hemery E, Servin AL (1998) Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 64: 4573-4580 [Google Scholar] [PubMed]
  3. O'Connor HJ (1994) Eradication of Helicobacter pylori. European journal of gastroenterology & hepatology 6: S113-S119
  4. Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum AL (2007) Helicobacter pylori and probiotics. The Journal of nutrition 137: 812S-818S [CrossRef] [Google Scholar]
  5. Gotteland M, Brunser O, Cruchet S (2006) Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther 23: 1077-1086 [CrossRef] [Google Scholar] [PubMed]
  6. Szajewska H, Horvath A, Piwowarczyk A (2010) Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 32: 1069-1079 [CrossRef] [Google Scholar] [PubMed]
  7. Baryshnikova NV (2011) Helicobacter pylori infection and colon dysbiosis. Lambert LAP Lambert Academic Publishing, pp 50-130
  8. Rustamov M, Baryshnikova N, Rustamova L (2016) Helicobacter 21 Suppl 1: 149
  9. Baryshnikova NV (2012) Helicobacter pylori-associated gastroenterological diseases: genetic features and probiotic treatment. Beneficial Microbes 3: 157-161 [CrossRef] [Google Scholar] [PubMed]
  10. Kim TS, Hur JW, Yu MA, Cheigh CI, Kim KN, et al. (2003) Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot 66: 3-12 [CrossRef] [Google Scholar] [PubMed]
  11. Ermolenko EI, Chernysh AI, Martsinkovskaia IV, Suvorov AN (2006) Influence of probiotic enterococci on the growth of Streptococcus agalactiae. Zh Mikrobiol Epidemiol Immunobiol 5: 73-77 [Google Scholar] [PubMed]
  12. Ermolenko EI (2009) Bacteriocins of enterococci, problems and perspectives of using. Vestn of Saint-Petrsburg university 11: 78-93
  13. Yermolenko E, Kolobov A, Chernysh A, Suvorov A (2011) Influence of synthetic peptide inductors on antibacterial activity of enterococci. Beneficial Microbes 2: 9-13 [CrossRef] [Google Scholar] [PubMed]
  14. Karaseva A, Tsapieva A, Pachebat J, Suvorov A (2016) Draft genome sequence of probiotic Enterococcus faecium strain L-3. Genome announcements. Genome Announc 4: e01622-15 [CrossRef] [Google Scholar] [PubMed]
  15. Ermolenko E (2011) Lactic acid bacteria Labert academic Publishing, Deutchland Labert, Deutchland: 283
  16. Suvorov AN, Simanenkov VI, Zakharova NV, Baryshnikova NV (2013) Efficacy of Enterococcus faecium L3 in therapy of Helicobacter pylori infection. International Scientific conference on bacteriocins and antimicrobial peptides, 28
  17. Suvorov A (2013) Gut microbiota, probiotics, and human health. Biosci Microbiota Food Health 32: 81-91 [CrossRef] [Google Scholar] [PubMed]
  18. Tsapieva A, Duplik N, Suvorov A (2011) Structure of plantaricin locus of Lactobacillus plantarum 8Р- А3. Benef Microbes 2: 255-261 [CrossRef] [Google Scholar] [PubMed]
  19. Zhebrun AB, Svarval' AV, Balabash OA, Ferman RS (2013) Helicobacter pylori population characteristic in patients with diseases of gastrointestinal tract. Zh Mikrobiol Epidemiol Immunobiol 2: 90-96 [Google Scholar] [PubMed]
  20. Sainsus N, Cattori V, Lepadatu C, Hofmann-Lehmann R (2008) Liquid culture medium for the rapid cultivation of Helicobacter pylori from biopsy specimens. Eur J Clin Microbiol Infect Dis 27: 1209-1217 [CrossRef] [Google Scholar] [PubMed]
  21. Suvorov A, Simanenkov V, Gromova L, Kolodjieva V, Tsapieva A, et al. (2011) Enterococci as probiotics or autoprobiotics. Prebiotics and probiotics potential for human health, Ivanova I (ed), Paisi Hilendarski, Sofia, 104-112
  22. Ermolenko EI, Isakov VA, Zhdan-Pushkina S, Tets VV (2003) Quantitative characterization of antagonistic activity of lactobacilli. Zhurnal mikrobiologii, epidemiologii, i immunobiologii 5: 94-98 [Google Scholar] [PubMed]